PineTree Therapeutics Funding: $24M Raised, Series A (2022)
PineTree Therapeutics is based in Cambridge, Massachusetts. It has raised $24M in total funding. Latest round: Series A.
PineTree Therapeutics funding overview
PineTree Therapeutics is based in Cambridge, Massachusetts. PineTree Therapeutics has raised $24M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in June 2022. The round record for PineTree Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include InterVest, SK Securities, DSC Investment, J Curve Investment, Samho Green Investment, SJ Investment Partners. 6 distinct backers are named across the disclosed rounds.
PineTree Therapeutics at a glance
Total raised
$24M
Latest round
Series A
Latest round date
June 2022
Headquarters
Cambridge, Massachusetts
Notable investors
InterVest, SK Securities, DSC Investment, J Curve Investment, Samho Green Investment, SJ Investment Partners
Frequently asked about PineTree Therapeutics funding
How much has PineTree Therapeutics raised?
PineTree Therapeutics has raised $24M in total disclosed funding across the rounds on record.
Who has invested in PineTree Therapeutics?
InterVest, SK Securities, DSC Investment, J Curve Investment, Samho Green Investment, SJ Investment Partners are named among the investors backing PineTree Therapeutics.
What was the latest PineTree Therapeutics funding round?
The most recent disclosed round is a Series A, announced in June 2022.
Where is PineTree Therapeutics based?
PineTree Therapeutics is based in Cambridge, Massachusetts.
When did PineTree Therapeutics last raise?
The last disclosed PineTree Therapeutics round closed in June 2022 at Series A.
PineTree Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
